Immupharma (IMM)

 

IMM Share PerformanceMore

52 week high70.32 17/02/17
52 week low30.79 24/06/16
52 week change 16.38 (45.49%)
4 week volume3,487,171 29/05/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Annual Report & Notice of AGM

RNS Number: 3430H Immupharma PLC 07 June 2017 7 June 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") ANNUAL REPORT AND ACCOUNTS POSTED TO SHAREHOLDERS NOTICE OF ANNUAL GENERAL MEETING ON 30 JUNE 2017 @ 10.30 AM INVESTOR PRESENTATION TO FOLLOW AT 11.30 AM VENUE: SKY LIGHT CITY...

ImmuPharma losses widen

ImmuPharma's overall losses rose to 5.3m in the year to the end of December - up from 3.9m in 2015. The group said this w...

Final Results

RNS Number: 7561G Immupharma PLC 01 June 2017 1 JUNE 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") FINAL RESULTS ANNOUNCEMENT for the twelve months ended 31 December 2016 ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to announce it...

Notification of Full Year Results

RNS Number: 7012F Immupharma PLC 22 May 2017 22 MAY 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") NOTIFICATION OF FULL YEAR RESULTS Date: 1 June 2017 ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended 31 Decembe...

Lupuzor study on track, says ImmuPharma

ImmuPharma's phase III clinical trial of Lupuzor, its lead programme for the potential breakthrough compound for Lupu...

Update on Lupuzor Phase III Study

RNS Number: 3534F Immupharma PLC 17 May 2017 17 MAY 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Update on Lupuzor Pivotal Phase III Study ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, is pleased to provide an update of its pivotal 52-week, randomised, double-blinded, Phase III clinical trial of L...

New Employee Share Option Plan & Grant of Options

New Employee Share Option Plan & Grant of Options

Fundamental DataMore

EPS-4.54
Dividend yield0 %

Latest discussion posts More

  • Re: 9.5% rise...

    Topped @ 49.25p ..10.06
    6-Jun-2017
    Ripley94
  • Re: 9.5% rise...

    sliced @ 8.45am @ 58.2p
    18-Apr-2017
    Ripley94
  • Re: 9.5% rise...

    Topped up (Thursday ) ( GTC Limit 49.75p ) on since Monday at least.
    6-Apr-2017
    Ripley94

Users' HoldingsMore

Users who hold Immupharma also hold..
LLOYDS GRP.27%
BP16%
NATIONAL GRID15%
ROYAL BANK SCOT12%
RENEURON12%

Codes & Symbols

ISINGB0033711010
SymbolsIMM, LSE:IMM, IMM.L, IMM:LN, LON:IMM, XLON:IMM